Urgent.News

What's breaking now, across thousands of outlets.

Science

STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field

The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. They could also have a chilling effect across the industry.

STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Science

More from Friday 11 September →